title: Does intensive outpatient cocaine treatment reduce AIDS risky behaviors?
abstract: The purposes of this study were: (1) to examine the characteristics of 447 cocaine dependent, first admission outpatients in relation to their AIDS risky behavior at intake; (2) to ascertain whether there was a reduction in risky behavior at follow-up 9 months after admission; and (3) to determine whether reductions in risky behavior were related to patient characteristics, group as compared to individual treatment, or time in treatment. In this sample of cocaine dependent patients entering outpatient treatment, those engaging in higher AIDS risky behaviors were not characterized by any particular demographic profile or by a lack of knowledge about HIV/AIDS. They did have higher scores on the SCL-90-R symptom scales, the Beck Depression Inventory, and higher ratings on the Drug, Alcohol, Family, and Medical scales of the ASI. At 9-month follow-up, AIDS risky behaviors as measured by the RAB were found to have decreased significantly. The degree of improvement was not associated with demographic variables but was predicted by higher intake problem severity and psychological symptomatology scale scores. While improvement in risky behavior was not related to type of treatment or duration of treatment, it was related to decreased substance use. The individuals whose risky behavior decreased were those whose substance use had decreased. Improvement, then required not only being in a treatment program, but also participation and involvement in the program. Treatment and not merely attendance would seem to be critical.
authors.affiliation: Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: E
authors.initials: E
authors.lastname: Gottheil
authors.forename: A
authors.initials: A
authors.lastname: Lundy
authors.forename: S P
authors.initials: SP
authors.lastname: Weinstein
authors.forename: R C
authors.initials: RC
authors.lastname: Sterling
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000523:psychology / Q000635:transmission*; D000328:Adult; D000553:Ambulatory Care; D019970:Cocaine-Related Disorders / Q000523:psychology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016485:Needle Sharing; D012309:Risk-Taking; D012725:Sexual Behavior